Blood Cancer United, a nonprofit organization, has made the rare decision to acquire the remaining supplies of Luvelta, an investigational cancer drug that has been discontinued.
This move aims to ensure that patients who may still benefit from Luvelta have access to the medication, despite its discontinuation.
The decision highlights the ongoing challenges in the availability of critical cancer treatments and the role of nonprofit organizations in addressing these gaps.
Updates
Update at 13:22 UTC on 2026-06-12
STAT reported The nonprofit Blood Cancer United is buying the remaining supplies of a discontinued investigational cancer drug, Luvelta.
Sources: STAT